These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25827356)

  • 21. Leveraging single-cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers.
    Bowes AL; Tarabichi M; Pillay N; Van Loo P
    J Pathol; 2022 Jul; 257(4):466-478. PubMed ID: 35438189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolutionary Mechanisms of Cancer Suggest Rational Therapeutic Approaches.
    Balzerano A; Paccosi E; Proietti-De-Santis L
    Cytogenet Genome Res; 2021; 161(6-7):362-371. PubMed ID: 34461614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying the influence of mutation detection on tumour subclonal reconstruction.
    Liu LY; Bhandari V; Salcedo A; Espiritu SMG; Morris QD; Kislinger T; Boutros PC
    Nat Commun; 2020 Dec; 11(1):6247. PubMed ID: 33288765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.
    Melchardt T; Magnes T; Hufnagl C; Thorner AR; Ducar M; Neureiter D; Tränkenschuh W; Klieser E; Gaggl A; Rösch S; Rasp G; Hartmann TN; Pleyer L; Rinnerthaler G; Weiss L; Greil R; Egle A
    Eur J Cancer; 2018 Apr; 93():69-78. PubMed ID: 29477794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing.
    Jiang Y; Qiu Y; Minn AJ; Zhang NR
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5528-37. PubMed ID: 27573852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational heterogeneity in cancer and the search for new cancer-associated genes.
    Lawrence MS; Stojanov P; Polak P; Kryukov GV; Cibulskis K; Sivachenko A; Carter SL; Stewart C; Mermel CH; Roberts SA; Kiezun A; Hammerman PS; McKenna A; Drier Y; Zou L; Ramos AH; Pugh TJ; Stransky N; Helman E; Kim J; Sougnez C; Ambrogio L; Nickerson E; Shefler E; Cortés ML; Auclair D; Saksena G; Voet D; Noble M; DiCara D; Lin P; Lichtenstein L; Heiman DI; Fennell T; Imielinski M; Hernandez B; Hodis E; Baca S; Dulak AM; Lohr J; Landau DA; Wu CJ; Melendez-Zajgla J; Hidalgo-Miranda A; Koren A; McCarroll SA; Mora J; Crompton B; Onofrio R; Parkin M; Winckler W; Ardlie K; Gabriel SB; Roberts CWM; Biegel JA; Stegmaier K; Bass AJ; Garraway LA; Meyerson M; Golub TR; Gordenin DA; Sunyaev S; Lander ES; Getz G
    Nature; 2013 Jul; 499(7457):214-218. PubMed ID: 23770567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer: evolution within a lifetime.
    Gerlinger M; McGranahan N; Dewhurst SM; Burrell RA; Tomlinson I; Swanton C
    Annu Rev Genet; 2014; 48():215-36. PubMed ID: 25292359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translating insights into tumor evolution to clinical practice: promises and challenges.
    Fittall MW; Van Loo P
    Genome Med; 2019 Mar; 11(1):20. PubMed ID: 30925887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioinformatics roadmap for therapy selection in cancer genomics.
    Jiménez-Santos MJ; García-Martín S; Fustero-Torre C; Di Domenico T; Gómez-López G; Al-Shahrour F
    Mol Oncol; 2022 Nov; 16(21):3881-3908. PubMed ID: 35811332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using single cell sequencing data to model the evolutionary history of a tumor.
    Kim KI; Simon R
    BMC Bioinformatics; 2014 Jan; 15():27. PubMed ID: 24460695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
    Luchini C; Bibeau F; Ligtenberg MJL; Singh N; Nottegar A; Bosse T; Miller R; Riaz N; Douillard JY; Andre F; Scarpa A
    Ann Oncol; 2019 Aug; 30(8):1232-1243. PubMed ID: 31056702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational Approaches for the Investigation of Intra-tumor Heterogeneity and Clonal Evolution from Bulk Sequencing Data in Precision Oncology Applications.
    Laganà A
    Adv Exp Med Biol; 2022; 1361():101-118. PubMed ID: 35230685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palimpsest: an R package for studying mutational and structural variant signatures along clonal evolution in cancer.
    Shinde J; Bayard Q; Imbeaud S; Hirsch TZ; Liu F; Renault V; Zucman-Rossi J; Letouzé E
    Bioinformatics; 2018 Oct; 34(19):3380-3381. PubMed ID: 29771315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.
    Zhang J; Liu J; Sun J; Chen C; Foltz G; Lin B
    Brief Bioinform; 2014 Mar; 15(2):244-55. PubMed ID: 23818492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer heterogeneity and signaling network-based drug target.
    Roukos DH
    Pharmacogenomics; 2013 Aug; 14(11):1243-6. PubMed ID: 23930670
    [No Abstract]   [Full Text] [Related]  

  • 37. Somatic clonal evolution: A selection-centric perspective.
    Scott J; Marusyk A
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):139-150. PubMed ID: 28161395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour heterogeneity and the evolution of polyclonal drug resistance.
    Burrell RA; Swanton C
    Mol Oncol; 2014 Sep; 8(6):1095-111. PubMed ID: 25087573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution and Impact of Subclonal Mutations in Papillary Thyroid Cancer.
    Masoodi T; Siraj AK; Siraj S; Azam S; Qadri Z; Parvathareddy SK; Al-Sobhi SS; AlDawish M; Alkuraya FS; Al-Kuraya KS
    Am J Hum Genet; 2019 Nov; 105(5):959-973. PubMed ID: 31668701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatially constrained tumour growth affects the patterns of clonal selection and neutral drift in cancer genomic data.
    Chkhaidze K; Heide T; Werner B; Williams MJ; Huang W; Caravagna G; Graham TA; Sottoriva A
    PLoS Comput Biol; 2019 Jul; 15(7):e1007243. PubMed ID: 31356595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.